0920 T&L Financials 01. qxd 12 6 09 16:53 Page 135 Notes to the consolidated financial statements 27 Share-based payments During the year to 31 March 2009, various equity-settled share-based payment arrangements existed, which are described below: Sharesave scheme Deferred Performance Executive share bonus Duration Type of arrangement share plan option scheme share plan in years Timing of grant Bi-annually Annually in June Annually in July Annually in June Annually in in June and note a December November Number of options shares granted in year to 31 March 2009 2 478 568 19 026 3 66 029 148 132 5 31 340 61 893 Number of options shares granted in year to 31 March 2008 1 511 463 429 612 3 102 128 215 130 5 57 335 104 183 Fair value per share for 2009 grant p 170 215 3 66 67 57576 Fair value per share for 2008 grant p 141 194 3 120 97 5 138 105 Valuation basis Monte Carlo Binomial Lattice Monte Carlo Black-Scholes Black-Scholes Contractual life 10 years 10 years 3 years 3 5 years 3 5 years Vesting conditions note b note c note d note e note e a The last grant under this scheme was made in June 2004. b Exercise is dependent on total shareholder return as measured by reference to a comparator group over a three-year period following grant.
Participants are not entitled to dividends prior to the exercise of options.
c Exercise is dependent on earnings per share performance relative to inflation over a three-year period following grant.
d Executives have the opportunity to defer up to 50% of their annual cash bonus after deduction of tax, national insurance or other social security payment and invest the amount deferred in the Companys shares.
Subject to the satisfaction of employment conditions and a performance target over the performance period as described in b above, participants will receive awards of matching shares based on the number of shares which could have been acquired from the gross bonus amount deferred by the participant.
During the performance period, dividends are paid on the deferred shares but not on matching shares.
This plan was suspended during the year.
Further details are set out in the directors remuneration report on page 87. e Options granted in the years to 31 March 2008 and 31 March 2009 were by invitation at a 10% discount to the market price.
Options are exercisable at the end of a three-year or five-year savings contract.
The Group recognised total expenses before tax of 5 million 2008 5 million related to equity-settled share-based payment transactions during the year.
Details of the movements for equity-settled share option schemes during the year to 31 March were as follows: 2009 2008 Weighted Weighted average average exercise exercise price price Number pence Number pence Outstanding at 1 April 11 664 517 117 14 100 394 163 Granted 2 804 988 42 2 419 851 87 Exercised 1 732 598 149 3 929 906 233 Lapsed 2 910 404 47 925 822 314 Outstanding at 31 March 9 826 503 111 11 664 517 117 Tate & Lyle Annual Report 2009 135 STATUTORY INFORMATION HOW WE RUN THE BUSINESS HOW WE PERFORMED WHAT WE DO OVERVIEW OF THE YEAR 0920 T&L Financials 01. qxd 12 6 09 16:53 Page 136 Notes to the consolidated financial statements 27 Share-based payments continued The weighted average Tate & Lyle PLC share price at the date of exercise for share options exercised during the year was 467 pence 2008 551 pence.
At 31 March 2009, 3,017,439 2008 3,346,475 of the outstanding options were exercisable at a weighted average exercise price of 280 pence 2008 328 pence.
A detailed breakdown of the range of exercise prices for options outstanding at 31 March is shown in the table below: 2009 2008 Weighted Weighted Weighted Weighted average average average average Number remaining exercise Number remaining exercise outstanding contractual price outstanding contractual price at end of year life in months pence at end of year life in months pence At nil cost 6 676 569 52.7 7 711 186 53.6 0.01 to 1.99 2.00 to 3.99 2 926 169 53.4 338 3 648 749 64.7 333 4.00 to 7.99 223 765 23.2 466 304 582 26.6 482 Total 9 826 503 52.3 93 11 664 517 56.5 117 The fair value of grants is measured using the valuation technique that is considered to be the most appropriate to value each class of grant.
These include Binomial Lattice models, Black-Scholes calculations and Monte Carlo simulations.
These valuations take into account factors such as non-transferability, exercise restrictions and behavioural considerations.
Key assumptions are detailed below: Sharesave Sharesave Deferred Performance scheme scheme At 31 March 2009 bonus plan share plan June December Expected volatility 30% 30% 30% 30% Expected life n a n a 3.5 5.5 years 3.5 5.5 years Risk-free rate 5.3% 4.5% 4.6% Expected dividend yield 5.6% 5.7% 5.7% 4.9% Forfeiture rate 0% 0% 10% 10% Correlation with comparators 30% 30% n a n a Volatility of comparators 17-56% 17-53% n a n a Expectations of meeting performance criteria 100% 100% n a n a Weighted average market price at date of grant p 401 392 398 400 Sharesave Sharesave Deferred Performance scheme scheme At 31 March 2008 bonus plan share plan June December Expected volatility 25% 25% 25% 30% Expected life n a n a 3.5 5.5 years 3.5 5.5 years Risk-free rate n a n a 6.0% 5.9% 4.5% 4.6% Expected dividend yield 3.6% 3.5% 3.8% 4.9% Forfeiture rate 0% 0% 10% 10% Correlation with comparators 20% 20% n a n a Volatility of comparators 5-47% 5-47% n a n a Expectations of meeting performance criteria 100% 100% n a n a Weighted average market price at date of grant p 568 576 531 439 The expected volatility is based on the Companys historical volatility over the three-year period prior to each award date.
